• FirefoxInstall the new Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.19%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.49 Up 0.11(7.97%) 12:53PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.38
    Open:1.46
    Bid:1.48 x 23000
    Ask:1.49 x 4500
    1y Target Est:4.17
    Beta:0.33
    Earnings Date:Mar 5 - Mar 9 (Est.)
    Day's Range:1.40 - 1.52
    52wk Range:1.19 - 3.18
    Volume:3,372,573
    Avg Vol (3m):972,152
    Market Cap:271.30M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PPHM

    Comparison

    Symbol% ChgMkt Cap
    PPHMUp 7.97%271.30M
    AMGNDown 0.99%119.44B
    NVSDown 0.42%246.03B
    RHHBYUp 0.47%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-15) :-0.30
    Quarterly EPS Est (Jan-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback